{"count": 49, "results": [{"_id": "35887957", "pmid": 35887957, "pmcid": "PMC9323116", "title": "Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review", "journal": "J Clin Med", "authors": ["Loh DKW", "Kadirvelu A", "Pamidi N"], "date": "2022-07-19T00:00:00Z", "doi": "10.3390/jcm11144193", "meta_date_publication": "2022 Jul 19", "meta_volume": "11", "meta_issue": "14", "meta_pages": "", "score": 50283.57, "text_hl": "This literature search aimed to encapsulate the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment on bone marrow density and @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@ in animal models. ", "citations": {"NLM": "Loh DKW, Kadirvelu A, Pamidi N. Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review J Clin Med. 2022 Jul 19;11(14):. PMID: 35887957", "BibTeX": "@article{35887957, title={Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review}, author={Loh DKW and Kadirvelu A and Pamidi N}, journal={J Clin Med}, volume={11}, number={14}}"}}, {"_id": "32441464", "pmid": 32441464, "pmcid": "PMC7348162", "title": "Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability", "journal": "J Cell Mol Med", "authors": ["Li B", "Po SS", "Zhang B", "Bai F", "Li J", "Qin F", "Liu N", "Sun C", "Xiao Y", "Tu T", "Zhou S", "Liu Q"], "date": "2020-07-01T00:00:00Z", "doi": "10.1111/jcmm.15407", "meta_date_publication": "2020 Jul", "meta_volume": "24", "meta_issue": "14", "meta_pages": "7751-7766", "score": 50260.254, "text_hl": "We investigated whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_MET @GENE_403438 @@@MET@@@) prevents @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@AF@@@-dependent @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@EAT remodelling@@@ and @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@AF@@@ vulnerability in @SPECIES_9615 @@@dogs@@@. ", "citations": {"NLM": "Li B, Po SS, Zhang B, Bai F, Li J, Qin F, Liu N, Sun C, Xiao Y, Tu T, Zhou S, Liu Q. Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability J Cell Mol Med. 2020 Jul;24(14):7751-7766. PMID: 32441464", "BibTeX": "@article{32441464, title={Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability}, author={Li B and Po SS and Zhang B and Bai F and Li J and Qin F and Liu N and Sun C and Xiao Y and Tu T and Zhou S and Liu Q}, journal={J Cell Mol Med}, volume={24}, number={14}, pages={7751-7766}}"}}, {"_id": "34383179", "pmid": 34383179, "title": "A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.", "journal": "Breast Cancer Res Treat", "authors": ["Tapia E", "Villa-Guillen DE", "Chalasani P", "Centuori S", "Roe DJ", "Guillen-Rodriguez J", "Huang C", "Galons JP", "Thomson CA", "Altbach M", "Trujillo J", "Pinto L", "Martinez JA", "Algotar AM", "Chow HS"], "date": "2021-11-01T00:00:00Z", "doi": "10.1007/s10549-021-06355-9", "meta_date_publication": "2021 Nov", "meta_volume": "190", "meta_issue": "1", "meta_pages": "69-78", "score": 50259.613, "text_hl": "A randomized controlled trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@women@@@ with components of @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@: intervention feasibility and effects on @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@ and breast density.", "citations": {"NLM": "Tapia E, Villa-Guillen DE, Chalasani P, Centuori S, Roe DJ, Guillen-Rodriguez J, Huang C, Galons JP, Thomson CA, Altbach M, Trujillo J, Pinto L, Martinez JA, Algotar AM, Chow HS. A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density. Breast Cancer Res Treat. 2021 Nov;190(1):69-78. PMID: 34383179", "BibTeX": "@article{34383179, title={A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.}, author={Tapia E and Villa-Guillen DE and Chalasani P and Centuori S and Roe DJ and Guillen-Rodriguez J and Huang C and Galons JP and Thomson CA and Altbach M and Trujillo J and Pinto L and Martinez JA and Algotar AM and Chow HS}, journal={Breast Cancer Res Treat}, volume={190}, number={1}, pages={69-78}}"}}, {"_id": "34495393", "pmid": 34495393, "title": "Metformin in Pregnancy for Women with Type 2 Diabetes: a Review.", "journal": "Curr Diab Rep", "authors": ["Benham JL", "Donovan LE", "Yamamoto JM"], "date": "2021-09-08T00:00:00Z", "doi": "10.1007/s11892-021-01409-0", "meta_date_publication": "2021 Sep 8", "meta_volume": "21", "meta_issue": "10", "meta_pages": "36", "score": 50252.977, "text_hl": "RECENT FINDINGS: A large, multicenter, double-blind randomized controlled trial found that @SPECIES_9606 @@@women@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ in pregnancy treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an adjunct to @GENE_INS @GENE_3630 @@@insulin@@@ therapy had less gestational @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@, @GENE_INS @GENE_3630 @@@insulin@@@ requirements, caesarian sections, @DISEASE_Fetal_Macrosomia @DISEASE_MESH:D005320 @@@macrosomia@@@, and neonatal @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@, but more neonates were @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@small for gestational age@@@ (@DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@SGA@@@) compared with @GENE_INS @GENE_3630 @@@insulin@@@ alone. ", "citations": {"NLM": "Benham JL, Donovan LE, Yamamoto JM. Metformin in Pregnancy for Women with Type 2 Diabetes: a Review. Curr Diab Rep. 2021 Sep 8;21(10):36. PMID: 34495393", "BibTeX": "@article{34495393, title={Metformin in Pregnancy for Women with Type 2 Diabetes: a Review.}, author={Benham JL and Donovan LE and Yamamoto JM}, journal={Curr Diab Rep}, volume={21}, number={10}, pages={36}}"}}, {"_id": "35817957", "pmid": 35817957, "title": "Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.", "journal": "Pediatr Res", "authors": ["Díaz M", "Carreras-Badosa G", "Villarroya J", "Gavaldà-Navarro A", "Bassols J", "de Zegher F", "López-Bermejo A", "Villarroya F", "Ibáñez L"], "date": "2022-07-11T00:00:00Z", "doi": "10.1038/s41390-022-02175-9", "meta_date_publication": "2022 Jul 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50248.793, "text_hl": "CONCLUSION: Prepubertal intervention with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces central @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@ and @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ in girls with reduced prenatal growth. ", "citations": {"NLM": "Díaz M, Carreras-Badosa G, Villarroya J, Gavaldà-Navarro A, Bassols J, de Zegher F, López-Bermejo A, Villarroya F, Ibáñez L. Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment. Pediatr Res. 2022 Jul 11;():. PMID: 35817957", "BibTeX": "@article{35817957, title={Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.}, author={Díaz M and Carreras-Badosa G and Villarroya J and Gavaldà-Navarro A and Bassols J and de Zegher F and López-Bermejo A and Villarroya F and Ibáñez L}, journal={Pediatr Res}}"}}, {"_id": "35204677", "pmid": 35204677, "pmcid": "PMC8961672", "title": "Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes", "journal": "Biomolecules", "authors": ["Salvatore T", "Galiero R", "Caturano A", "Vetrano E", "Rinaldi L", "Coviello F", "Di Martino A", "Albanese G", "Colantuoni S", "Medicamento G", "Marfella R", "Sardu C", "Sasso FC"], "date": "2022-01-21T00:00:00Z", "doi": "10.3390/biom12020176", "meta_date_publication": "2022 Jan 21", "meta_volume": "12", "meta_issue": "2", "meta_pages": "", "score": 50248.273, "text_hl": "In addition to representing a potential CV risk factor, emerging evidence shows that EAT may guide the therapeutic decision in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ as drugs such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 inhibitors (SGLT2-Is), have been associated with attenuation of @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@EAT enlargement@@@.", "citations": {"NLM": "Salvatore T, Galiero R, Caturano A, Vetrano E, Rinaldi L, Coviello F, Di Martino A, Albanese G, Colantuoni S, Medicamento G, Marfella R, Sardu C, Sasso FC. Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes Biomolecules. 2022 Jan 21;12(2):. PMID: 35204677", "BibTeX": "@article{35204677, title={Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes}, author={Salvatore T and Galiero R and Caturano A and Vetrano E and Rinaldi L and Coviello F and Di Martino A and Albanese G and Colantuoni S and Medicamento G and Marfella R and Sardu C and Sasso FC}, journal={Biomolecules}, volume={12}, number={2}}"}}, {"_id": "31445961", "pmid": 31445961, "title": "Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice.", "journal": "Can J Diabetes", "authors": ["Ryan PM", "Patterson E", "Carafa I", "Mandal R", "Wishart DS", "Dinan TG", "Cryan JF", "Tuohy KM", "Stanton C", "Ross RP"], "date": "2020-03-01T00:00:00Z", "doi": "10.1016/j.jcjd.2019.05.008", "meta_date_publication": "2020 Mar", "meta_volume": "44", "meta_issue": "2", "meta_pages": "146-155.e2", "score": 50247.96, "text_hl": "Paradoxically, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also reduced alpha diversity, a metric frequently associated with host metabolic fitness. ", "citations": {"NLM": "Ryan PM, Patterson E, Carafa I, Mandal R, Wishart DS, Dinan TG, Cryan JF, Tuohy KM, Stanton C, Ross RP. Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice. Can J Diabetes. 2020 Mar;44(2):146-155.e2. PMID: 31445961", "BibTeX": "@article{31445961, title={Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice.}, author={Ryan PM and Patterson E and Carafa I and Mandal R and Wishart DS and Dinan TG and Cryan JF and Tuohy KM and Stanton C and Ross RP}, journal={Can J Diabetes}, volume={44}, number={2}, pages={146-155.e2}}"}}, {"_id": "34360870", "pmid": 34360870, "pmcid": "PMC8347264", "title": "Maternal Metformin Intervention during Obese Glucose-Intolerant Pregnancy Affects Adiposity in Young Adult Mouse Offspring in a Sex-Specific Manner", "journal": "Int J Mol Sci", "authors": ["Schoonejans JM", "Blackmore HL", "Ashmore TJ", "Aiken CE", "Fernandez-Twinn DS", "Ozanne SE"], "date": "2021-07-28T00:00:00Z", "doi": "10.3390/ijms22158104", "meta_date_publication": "2021 Jul 28", "meta_volume": "22", "meta_issue": "15", "meta_pages": "", "score": 50247.668, "text_hl": "The mechanism by which @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ causes @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@ in male offspring is unclear. ", "citations": {"NLM": "Schoonejans JM, Blackmore HL, Ashmore TJ, Aiken CE, Fernandez-Twinn DS, Ozanne SE. Maternal Metformin Intervention during Obese Glucose-Intolerant Pregnancy Affects Adiposity in Young Adult Mouse Offspring in a Sex-Specific Manner Int J Mol Sci. 2021 Jul 28;22(15):. PMID: 34360870", "BibTeX": "@article{34360870, title={Maternal Metformin Intervention during Obese Glucose-Intolerant Pregnancy Affects Adiposity in Young Adult Mouse Offspring in a Sex-Specific Manner}, author={Schoonejans JM and Blackmore HL and Ashmore TJ and Aiken CE and Fernandez-Twinn DS and Ozanne SE}, journal={Int J Mol Sci}, volume={22}, number={15}}"}}, {"_id": "32951009", "pmid": 32951009, "pmcid": "PMC7855162", "title": "Metformin effectively restores the HPA axis function in diet-induced obese rats", "journal": "Int J Obes (Lond)", "authors": ["Shin AC", "Balasubramanian P", "Suryadevara P", "Zyskowski J", "Herdt TH", "MohanKumar SMJ", "MohanKumar PS"], "date": "2021-02-01T00:00:00Z", "doi": "10.1038/s41366-020-00688-z", "meta_date_publication": "2021 Feb", "meta_volume": "45", "meta_issue": "2", "meta_pages": "383-395", "score": 50247.14, "text_hl": "Recent @SPECIES_9606 @@@human@@@ and animal studies have shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can also effectively lower body weight and @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@. ", "citations": {"NLM": "Shin AC, Balasubramanian P, Suryadevara P, Zyskowski J, Herdt TH, MohanKumar SMJ, MohanKumar PS. Metformin effectively restores the HPA axis function in diet-induced obese rats Int J Obes (Lond). 2021 Feb;45(2):383-395. PMID: 32951009", "BibTeX": "@article{32951009, title={Metformin effectively restores the HPA axis function in diet-induced obese rats}, author={Shin AC and Balasubramanian P and Suryadevara P and Zyskowski J and Herdt TH and MohanKumar SMJ and MohanKumar PS}, journal={Int J Obes (Lond)}, volume={45}, number={2}, pages={383-395}}"}}, {"_id": "35664477", "pmid": 35664477, "pmcid": "PMC9157591", "title": "Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity", "journal": "Front Psychiatry", "authors": ["Huang J", "Pham M", "Panenka WJ", "Honer WG", "Barr AM"], "date": "2022-05-18T00:00:00Z", "doi": "10.3389/fpsyt.2022.891512", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "891512", "score": 50246.188, "text_hl": "Both high dose @CHEMICAL_Psilocybin @CHEMICAL_MESH:D011562 @@@psilocybin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreased consumption of the high calorie diet, and exhibited decreased central @<m>DISEASE_Neoplasms_Adipose_Tissue</m> @DISEASE_MESH:D018205 @@@adiposity@@@.", "citations": {"NLM": "Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity Front Psychiatry. 2022;13():891512. PMID: 35664477", "BibTeX": "@article{35664477, title={Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity}, author={Huang J and Pham M and Panenka WJ and Honer WG and Barr AM}, journal={Front Psychiatry}, volume={13}, pages={891512}}"}}]}